Answers are grounded in this paper and cite their sources.
, did not develop resistance in STM upon repeated exposure to sublethal doses up to the 160th cycle, whereas resistance against the clinically used antibacterial ciprofloxacin began emerging from the 32nd cycle and became significant by the end of the 128th cycle. These preliminary findings open avenues for developing novel antimicrobial agents with enhanced durability against drug resistance, as disclosed in this study.
No takes yet. Share an insight, caveat, or question.
Ganaie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: